The Anderson Perspective

Soaring prescription drug prices, especially for specialty medications, are putting immense pressure on employers. A growing number are turning to consultants to navigate the complex world of pharmacy benefit managers and regain control of healthcare spending.

ARS Pharmaceuticals is challenging the epinephrine auto-injector status quo with its nasal spray and new program offering virtual consultations and potential $0 co-pay. This innovative approach seeks to improve access and convenience for allergy sufferers.

A new interactive map reveals the alarming rise of 'pharmacy deserts' across the U.S., disproportionately impacting rural and low-income communities. What’s driving this trend and what can be done?

New tech-enabled service, VantaStat, bypasses ER delays and lengthy waits by connecting patients directly with orthopedic specialists, potentially reshaping urgent MSK care in the DMV.

Levitate’s attainment of HIPAA compliance positions it to deliver personalized marketing solutions to dental and chiropractic practices, addressing a growing demand for patient-centric care and data privacy.

A new ecosystem combining peritoneal dialysis with remote monitoring and data analytics aims to address low adoption rates of home dialysis, promising improved patient outcomes and reduced healthcare costs.

A new ranking system from U.S. News & World Report aims to bring much-needed transparency to the rapidly growing home healthcare market, where millions rely on post-hospitalization care.

The FDA has authorized Pulsenmore’s home-use prenatal ultrasound device, potentially revolutionizing access to care for expectant mothers in underserved areas and reshaping the future of prenatal monitoring.

Sigrid Therapeutics is shifting its sales strategy, moving from direct-to-consumer to a physician-led model in the US. The company hopes its clinically-backed 'Glucose Stabiliser' will gain traction in a crowded market.

Breakthrough cancer treatment recognized for impact, but accessibility remains a concern as researchers explore potential beyond oncology. A look at the future of personalized medicine.

Abbott's AVEIR DR system, the first dual-chamber leadless pacemaker, is poised to transform cardiac care, offering patients greater freedom, reduced complications, and a new lease on life. The technology is challenging existing market dynamics.

Medical device company Glucotrack appoints pain management expert to advisory team as it advances innovative approach combining glucose monitoring with spinal cord stimulation for chronic pain.

Rosalind Franklin University researchers are pushing the boundaries of reproductive medicine, offering innovative diagnostic tools and unraveling the complex role of the immune system in pregnancy success.

Amelia Aesthetics is rapidly expanding its network of plastic surgery centers, leveraging technology and streamlined workflows to meet growing demand for breast augmentation while prioritizing the patient experience. Is this model sustainable?